Hallucinations and delusions from psychosis are not uncommon for people living with Parkinson’s disease (PD). According to the Parkinson’s Foundation, between 20-40% of people living with PD report hallucinations with the likelihood increasing as someone living with PD ages. The only FDA-approved medication for hallucinations in Parkinson disease is pimavanserin (commonly sold…
Congratulations to Winston T. Chu, Jesse Hall, Anjela Gurrala, Alexander Becsey, Shreya Raman, Michael S. Okun, Catherine T. Flores, Benoit I. Giasson, David E. Vaillancourt, and Vinata Vedam-Mai on the publication of “Evaluation of an Adoptive Cellular Therapy-Based Vaccine in…
Congratulations to Drs Hubert H. Fernandez, Michael S. Okun, and Dawn Bowers on the publication of “A pilot trial of dopamine replacement for dynamic facial expressions in Parkinson’s disease,” which was published in the October 20th issue of Movement Disorders Clinical Practice.
Congratulations to Dr. Okun on the publication of “Muhammad Ali and Young-Onset Idiopathic Parkinson Disease—The Missing Evidence.” This paper was published in the October 24th edition of JAMA Neurology. Following Muhammad Ali’s death, there has been persistent dialogue about the degree to which Parkinson disease vs repetitive boxing-related head trauma…
Congratulations Drs. JanineLopes, Kelly D.Foote, Michael S. Okun on the publication of “Distinct roles of the human subthalamic nucleus and dorsal pallidum in Parkinson’s disease impulsivity,” in the March issue of…
Congratulations Dr Nikolaus McFarland, on the publication of “The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism,” in the March 1 issue of Nature Portfolio Journals. Abstract The Trial of Parkinson’s And Zoledronic acid (TOPAZ, https://clinicaltrials.gov/ct2/show/NCT03924414) is a unique collaboration between experts…
Congratulations Dr. Nikolaus McFarland on the publication of “A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson’s Disease in Clinical Practice: An International Study.” This paper was published in the November 2020 issue of Movement Disorders. ABSTRACT Background Enlargement of the third ventricle has been…
Congratulations Bonnie M. Scott, Robert S. Eisinger, Matthew R. Burns, Janine Lopes, Michael S. Okun, Aysegul…
Congratulations Takashi Tsuboi, Adolfo Ramirez-Zamora, Janine Lemos Melo Lobo Jofili Lopes, Leonardo Almeida, Pamela Zeilman, Robert Eisinger, Kelly Foote, and Michael Okun for you publication of “Pallidal Connectivity Profiling of Stimulation‐Induced Dyskinesia in Parkinson’s Disease,” in the October issue of Movement Disorders. ABSTRACT Objectives The aim of this study…
Congratulations Drs. Janine Lopes, and Michael Okun on the publication of “Pavlovian bias in Parkinson’s disease: an objective marker of impulsivity that modulates with deep brain stimulation.” This article was published in the August edition of Scientific Reports. Abstract Impulsivity is a common symptom in Parkinson’s disease (PD). Adaptive behavior…
